Basics Vaxcyte, Inc. IPO Date: July 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $4.09B Activated in VL: True Average Daily Range Avg Daily Range: $1.04 | 2.57% Avg Daily Range (30 D): $1.14 | 3.49% Avg Daily Range (90 D): $1.60 | 3.28% Institutional Daily Volume Avg Daily Volume: .56M Avg Daily Volume (30 D): 1.9M Avg Daily Volume (90 D): 1.77M Trade Size Avg Trade Size (Sh.): 60 Avg Trade Size (Sh.) (30 D): 67 Avg Trade Size (Sh.) (90 D): 66 Institutional Trades Total Inst.Trades: 3,171 Avg Inst. Trade: $3.72M Avg Inst. Trade (30 D): $3.09M Avg Inst. Trade (90 D): $3.69M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $7.27M Avg Closing Trade (30 D): $8.85M Avg Closing Trade (90 D): $11.67M Avg Closing Volume: 129.37K         News Mar 31, 2025 @ 12:56 PM Vaxcyte Plans To Drop Developing One Pneumococcal ... Source: Vandana Singh Jan 30, 2025 @ 4:51 PM Kuehn Law Encourages Investors of Vaxcyte, Inc. to... Source: N/A Jan 1, 2025 @ 9:27 AM Trump and Interest Rates: The 2 Key Reasons This V... Source: Anthony Di Pizio Sep 5, 2024 @ 3:58 AM Vaxcyte Announces Pricing of $1.3 Billion Public O... Source: N/A Sep 3, 2024 @ 8:01 PM Vaxcyte Announces Commencement of Proposed Public ... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.99 $-1.04 $-1.02 Diluted EPS $-3.99 $-1.04 $-1.02 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -509.63M $ -140.72M $ -137.08M Operating Income / Loss $ -635.87M $ -180.79M $ -162.17M Cost of Revenue $ $ $ Net Cash Flow $ -264.45M $ -41.03M $ -662.31M PE Ratio